Nulify Tablet DT
By Nulify
Rx
10 Tablet DT in a Strip

Composition
Levocetirizine(NA) + Montelukast(NA)

Manufacturer - Gold Line

Expires on or after
October, 2025

liver
Nulify Tablet DT should be used carefully in individuals with severe liver disease. It may be necessary to adjust the dosage of the medication. It is important to consult your doctor before taking this medicine. There is limited information regarding the use of Nulify Tablet DT in patients with liver issues, so caution is advised. However, no dose adjustment is typically required for individuals with mild to moderate liver disease.

kidney
Nulify Tablet DT should be used carefully in patients with kidney disease. Adjusting the dose may be necessary. It is not recommended for patients with severe kidney disease. Consult your doctor for guidance.

alcohol
When taking Nulify Tablet DT, it is advised to be cautious while consuming alcohol. It is recommended to consult your doctor regarding alcohol intake.

driving
Nulify Tablet DT may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Nulify Tablet DT is generally safe during pregnancy based on animal studies with limited human data. It is advisable to consult with a healthcare provider for personalized advice.

breastfeeding
Nulify Tablet DT should be avoided during breastfeeding as it can be harmful to the baby. There is a risk of toxicity associated with the drug.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹50
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025